Bradford T Whitmore bought $268K of Ultralife (ULBI)
Executed Nov 19 2025, disclosed Nov 21 2025, 2 days later.
Over the 21 trading sessions from the disclosed entry session (Nov 21 2025), the stock returned +15.9% (delay-adjusted); from the execution session (Nov 19 2025), +14.9%. Derived: entry at the session's open, exit at the close 20 sessions later.
Bradford T Whitmore (Director) filed 4 Form 4 reports in the trailing twelve months (4 purchases, 0 sales), most often in Ultralife Corporation (ULBI). Across 4 priced purchase filings, the average 21-session return was +15.5% from execution and +11.8% from disclosure (delay-adjusted; derived). The largest single filing was $1.2M of ULBI (187,512 sh across 3 lots, as filed), executed Mar 12.
Industrials · Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electron…
More Industrials filings→ Insider filings, newest first→ View the original filing at www.sec.gov→100,178 sh across 2 lots
Exec May 21
Filed May 26 · 4:18 PM ET ULBIPURCHASE Ultralife Corporation $1.2M
187,512 sh across 3 lots
Exec Mar 12
Filed Mar 16 · 4:25 PM ET ULBIPURCHASE Ultralife Corporation $163K
28,588 sh × $5.70
Exec Dec 16 2025
Filed Dec 16 2025 · 4:32 PM ET ULBIPURCHASE Ultralife Corporation $302K
45,664 sh across 2 lots
Exec Aug 19 2025
Filed Aug 21 2025 · 4:58 PM ET